/ Print /

Pharmacy Best Practices

Oral specialty drug options on the horizon
Oral specialty drug options on the horizonAs more specialty drugs are approved, cost control strategies are key.
Trump declares Opioid ‘National Emergency’: 3 healthcare impactsExperts share how the declaration could affect how the opioid epidemic is managed.
Controversy surrounds Exondys 51 approval: What to knowNew medicine for Duchenne muscular dystrophy raises questions. Here’s whose covering it and why.
Three ways integration focuses on customersHere are three ways HealthPartners’ health plan and care delivery system work together to save customers time and money and improve their experience.
Clinical pharmacists gain prominence as the industry changes
Clinical pharmacists gain prominence as the industry changesPayers realize value in partnering with pharmacists to manage medication-related complications
Evolving hepatitis C pipeline offers hope to patients
Evolving hepatitis C pipeline offers hope to patientsCost burden prompts payers to consider appropriate utilization
Six barriers to prescribing PCSK9 inhibitorsA National Lipid Association survey has interesting findings on the prescription approval process for PCSK9 inhibitors.
Managed Care Pharmacy Survey 2017To identify the top managed care pharmacy challenges and what your peers are doing about them, Managed Healthcare Executive conducted its annual pharmacy survey during the first quarter of 2017.
Five ways to combat growing polypharmacy among childrenOne expert believes managed care executives are key to a necessary paradigm shift in pediatric polypharmacy.
Top 10 states with the worst drug problemsWalletHub released a study comparing 50 states and the District in terms of 15 key metrics, ranging from arrest and overdose rates to opioid prescriptions and meth-lab incidents per capita.